Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Multicenter Study Using Desorption-Electrospray-Ionization-Mass-Spectrometry Imaging for Breast-Cancer Diagnosis.

Porcari AM, Zhang J, Garza KY, Rodrigues-Peres RM, Lin JQ, Young JH, Tibshirani R, Nagi C, Paiva GR, Carter SA, Sarian LO, Eberlin MN, Eberlin LS.

Anal Chem. 2018 Sep 18. doi: 10.1021/acs.analchem.8b01961. [Epub ahead of print]

PMID:
30170496
2.

Granulomatous mastitis: etiology, imaging, pathology, treatment, and clinical findings.

Barreto DS, Sedgwick EL, Nagi CS, Benveniste AP.

Breast Cancer Res Treat. 2018 Oct;171(3):527-534. doi: 10.1007/s10549-018-4870-3. Epub 2018 Jul 3. Review.

PMID:
29971624
3.

Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.

Johnston AN, Bu W, Hein S, Garcia S, Camacho L, Xue L, Qin L, Nagi C, Hilsenbeck SG, Kapali J, Podsypanina K, Nangia J, Li Y.

Breast Cancer Res. 2018 May 19;20(1):42. doi: 10.1186/s13058-018-0969-z.

4.

Case Report: Metastatic Phyllodes Tumor.

Ruiz-Flores L, Ebuoma LO, Benveniste MF, Nagi C, OrtizPerez T, Benveniste AP.

Semin Ultrasound CT MR. 2018 Feb;39(1):122-126. doi: 10.1053/j.sult.2017.05.011. Epub 2017 Jun 23.

PMID:
29317034
5.

Corrigendum: Mechanism of early dissemination and metastasis in Her2+ mammary cancer.

Harper KL, Sosa MS, Entenberg D, Hosseini H, Cheung JF, Nobre R, Avivar-Valderas A, Nagi C, Girnius N, Davis RJ, Farias EF, Condeelis J, Klein CA, Aguirre-Ghiso JA.

Nature. 2018 Jan 18;553(7688):366. doi: 10.1038/nature24666. Epub 2017 Dec 13.

PMID:
29236689
6.

Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system.

Zhang J, Rector J, Lin JQ, Young JH, Sans M, Katta N, Giese N, Yu W, Nagi C, Suliburk J, Liu J, Bensussan A, DeHoog RJ, Garza KY, Ludolph B, Sorace AG, Syed A, Zahedivash A, Milner TE, Eberlin LS.

Sci Transl Med. 2017 Sep 6;9(406). pii: eaan3968. doi: 10.1126/scitranslmed.aan3968.

7.

Spindle cell lesions of the breast: Multimodality imaging and clinical differentiation of pathologically similar neoplasms.

Raj SD, Sweetwood K, Kapoor MM, Raj KM, Nagi C, Sepulveda KA, Sedgwick EL.

Eur J Radiol. 2017 May;90:60-72. doi: 10.1016/j.ejrad.2017.02.019. Epub 2017 Feb 16. Review.

PMID:
28583649
8.

HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer.

Xu X, De Angelis C, Burke KA, Nardone A, Hu H, Qin L, Veeraraghavan J, Sethunath V, Heiser LM, Wang N, Ng CKY, Chen ES, Renwick A, Wang T, Nanda S, Shea M, Mitchell T, Rajendran M, Waters I, Zabransky DJ, Scott KL, Gutierrez C, Nagi C, Geyer FC, Chamness GC, Park BH, Shaw CA, Hilsenbeck SG, Rimawi MF, Gray JW, Weigelt B, Reis-Filho JS, Osborne CK, Schiff R.

Clin Cancer Res. 2017 Sep 1;23(17):5123-5134. doi: 10.1158/1078-0432.CCR-16-2191. Epub 2017 May 9.

9.

Detection of Metastatic Breast and Thyroid Cancer in Lymph Nodes by Desorption Electrospray Ionization Mass Spectrometry Imaging.

Zhang J, Feider CL, Nagi C, Yu W, Carter SA, Suliburk J, Cao HST, Eberlin LS.

J Am Soc Mass Spectrom. 2017 Jun;28(6):1166-1174. doi: 10.1007/s13361-016-1570-2. Epub 2017 Feb 28.

10.

Mechanism of early dissemination and metastasis in Her2+ mammary cancer.

Harper KL, Sosa MS, Entenberg D, Hosseini H, Cheung JF, Nobre R, Avivar-Valderas A, Nagi C, Girnius N, Davis RJ, Farias EF, Condeelis J, Klein CA, Aguirre-Ghiso JA.

Nature. 2016 Dec 14. doi: 10.1038/nature20609. [Epub ahead of print] Erratum in: Nature. 2017 Dec 13;:.

11.

Lactation opposes pappalysin-1-driven pregnancy-associated breast cancer.

Takabatake Y, Oxvig C, Nagi C, Adelson K, Jaffer S, Schmidt H, Keely PJ, Eliceiri KW, Mandeli J, Germain D.

EMBO Mol Med. 2016 Apr 1;8(4):388-406. doi: 10.15252/emmm.201606273.

12.

Breast pathology review: does it make a difference?

Romanoff AM, Cohen A, Schmidt H, Weltz CR, Jaffer SM, Nagi CS, Bleiweiss IJ, Port ER.

Ann Surg Oncol. 2014 Oct;21(11):3504-8. doi: 10.1245/s10434-014-3792-5. Epub 2014 May 24.

PMID:
24859936
13.

Characteristics of breast carcinoma cases with false-negative sentinel lymph nodes.

Wei S, Bleiweiss IJ, Nagi C, Jaffer S.

Clin Breast Cancer. 2014 Aug;14(4):280-4. doi: 10.1016/j.clbc.2013.12.009. Epub 2014 Jan 3.

PMID:
24581736
14.

Should incidental microscopic radiologically occult atypical duct hyperplasia of the breast be excised?

Jaffer S, Nagi C, Bleiweiss IJ.

Breast J. 2014 Jan-Feb;20(1):103-4. doi: 10.1111/tbj.12218. Epub 2013 Nov 22. No abstract available.

PMID:
24261935
15.

Forensic case formulation: theoretical, ethical and practical issues.

Davies J, Black S, Bentley N, Nagi C.

Crim Behav Ment Health. 2013 Oct;23(4):304-14. doi: 10.1002/cbm.1882.

PMID:
24101410
16.

N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties.

Qian X, Anzovino A, Kim S, Suyama K, Yao J, Hulit J, Agiostratidou G, Chandiramani N, McDaid HM, Nagi C, Cohen HW, Phillips GR, Norton L, Hazan RB.

Oncogene. 2014 Jun 26;33(26):3411-21. doi: 10.1038/onc.2013.310. Epub 2013 Aug 26.

17.

Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses.

Das S, Sarrou E, Podgrabinska S, Cassella M, Mungamuri SK, Feirt N, Gordon R, Nagi CS, Wang Y, Entenberg D, Condeelis J, Skobe M.

J Exp Med. 2013 Jul 29;210(8):1509-28. doi: 10.1084/jem.20111627. Epub 2013 Jul 22.

18.

Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations.

Tulchin N, Ornstein L, Dikman S, Strauchen J, Jaffer S, Nagi C, Bleiweiss I, Kornreich R, Edelmann L, Brown K, Bodian C, Nair VD, Chambon M, Woods NT, Monteiro AN.

Cancer Cell Int. 2013 Jul 15;13(1):70. doi: 10.1186/1475-2867-13-70.

19.

Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.

Mosoyan G, Nagi C, Marukian S, Teixeira A, Simonian A, Resnick-Silverman L, DiFeo A, Johnston D, Reynolds SR, Roses DF, Mosoian A.

PLoS One. 2013;8(1):e55145. doi: 10.1371/journal.pone.0055145. Epub 2013 Jan 25.

20.

Incidental intraductal papillomas (<2 mm) of the breast diagnosed on needle core biopsy do not need to be excised.

Jaffer S, Bleiweiss IJ, Nagi C.

Breast J. 2013 Mar-Apr;19(2):130-3. doi: 10.1111/tbj.12073. Epub 2013 Jan 21.

PMID:
23336823
21.

A multidisciplinary approach to team nursing within a low secure service: the team leader role.

Nagi C, Davies J, Williams M, Roberts C, Lewis R.

Perspect Psychiatr Care. 2012 Jan;48(1):56-61. doi: 10.1111/j.1744-6163.2011.00310.x. Epub 2011 May 23. Review.

PMID:
22188048
22.

PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment.

Avivar-Valderas A, Salas E, Bobrovnikova-Marjon E, Diehl JA, Nagi C, Debnath J, Aguirre-Ghiso JA.

Mol Cell Biol. 2011 Sep;31(17):3616-29. doi: 10.1128/MCB.05164-11. Epub 2011 Jun 27.

23.

Benign mucocele-like lesions of the breast: revisited.

Jaffer S, Bleiweiss IJ, Nagi CS.

Mod Pathol. 2011 May;24(5):683-7. doi: 10.1038/modpathol.2010.235. Epub 2011 Jan 14.

24.

Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases.

Das S, Ladell DS, Podgrabinska S, Ponomarev V, Nagi C, Fallon JT, Skobe M.

Cancer Res. 2010 Mar 1;70(5):1814-24. doi: 10.1158/0008-5472.CAN-09-3675. Epub 2010 Feb 23.

25.

Adequate histologic sampling of breast magnetic resonance imaging-guided core needle biopsy.

Cornea V, Jaffer S, Bleiweiss IJ, Nagi C.

Arch Pathol Lab Med. 2009 Dec;133(12):1961-4. doi: 10.1043/1543-2165-133.12.1961.

PMID:
19961252
26.

Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy.

Jaffer S, Nagi C, Bleiweiss IJ.

Cancer. 2009 Jul 1;115(13):2837-43. doi: 10.1002/cncr.24321.

27.

Intraductal carcinoma arising in intraductal papilloma in an axillary lymph node: review of the literature and proposed theories of evolution.

Jaffer S, Lin R, Bleiweiss IJ, Nagi C.

Arch Pathol Lab Med. 2008 Dec;132(12):1940-2. doi: 10.1043/1543-2165-132.12.1940. Review.

PMID:
19061295
28.

Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node negative patients with 20-year follow-up.

Jaffer S, Nagi C, Bleiweiss IJ.

Adv Anat Pathol. 2008 Nov;15(6):370-3. doi: 10.1097/PAP.0b013e31818a64e5. No abstract available.

PMID:
18948766
29.

Unusual presentation of sarcoidosis of the breast.

Hermann G, Nagi C, Mester J, Tierstein A.

Br J Radiol. 2008 Sep;81(969):e231-3. doi: 10.1259/bjr/11877313.

PMID:
18769011
30.

Lobular neoplasia on core needle biopsy does not require excision.

Nagi CS, O'Donnell JE, Tismenetsky M, Bleiweiss IJ, Jaffer SM.

Cancer. 2008 May 15;112(10):2152-8. doi: 10.1002/cncr.23415.

31.

Immunohistochemical detection of X-linked inhibitor of apoptosis in head and neck squamous cell carcinoma.

Nagi C, Xiao GQ, Li G, Genden E, Burstein DE.

Ann Diagn Pathol. 2007 Dec;11(6):402-6. Epub 2007 Sep 14.

PMID:
18022123
32.

Cell-graph mining for breast tissue modeling and classification.

Bilgin C, Demir C, Nagi C, Yener B.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:5311-4.

PMID:
18003206
33.

Atypical ductal hyperplasia at margin of breast biopsy--is re-excision indicated?

Arora S, Menes TS, Moung C, Nagi C, Bleiweiss I, Jaffer S.

Ann Surg Oncol. 2008 Mar;15(3):843-7. Epub 2007 Nov 7.

PMID:
17987337
34.

Incidental metastatic microcarcinoma of the thyroid identified after total parathyroidectomy.

Mazeh H, Divino C, Nagi C, Bleiweiss IJ, Weber K.

Thyroid. 2007 Jul;17(7):685-7.

PMID:
17696841
37.
38.

Endocervical glandular involvement is associated with high-grade SIL.

Nagi CS, Schlosshauer PW.

Gynecol Oncol. 2006 Aug;102(2):240-3. Epub 2006 Feb 9.

PMID:
16472847
39.

N-cadherin expression in breast cancer: correlation with an aggressive histologic variant--invasive micropapillary carcinoma.

Nagi C, Guttman M, Jaffer S, Qiao R, Keren R, Triana A, Li M, Godbold J, Bleiweiss IJ, Hazan RB.

Breast Cancer Res Treat. 2005 Dec;94(3):225-35.

PMID:
16258702
40.

Epithelial displacement in breast lesions: a papillary phenomenon.

Nagi C, Bleiweiss I, Jaffer S.

Arch Pathol Lab Med. 2005 Nov;129(11):1465-9.

PMID:
16253028
41.

Thinking "out of the nest"--a reply to "a stem-cell role for thyroid solid cell nests [letter]".

Burstein DE, Unger P, Nagi C, Wang BY.

Hum Pathol. 2005 May;36(5):591-2. No abstract available.

PMID:
15948130
43.

Mohs micrographically controlled surgery and the treatment of malignant melanoma.

Nagi C, O'Grady TC, Izadpanah A.

Semin Oncol. 2002 Aug;29(4):336-40. Review.

PMID:
12170436
44.

Subcutaneous T-cell lymphoma with associated hemophagocytic syndrome and terminal leukemic transformation.

Romero LS, Goltz RW, Nagi C, Shin SS, Ho AD.

J Am Acad Dermatol. 1996 May;34(5 Pt 2):904-10. Review.

PMID:
8621826
45.

Primary cutaneous aspergillosis near central venous catheters in patients with the acquired immunodeficiency syndrome.

Hunt SJ, Nagi C, Gross KG, Wong DS, Mathews WC.

Arch Dermatol. 1992 Sep;128(9):1229-32.

PMID:
1519937
46.

Treatment of basal cell carcinoma with intralesional interferon.

Greenway HT, Cornell RC, Tanner DJ, Peets E, Bordin GM, Nagi C.

J Am Acad Dermatol. 1986 Sep;15(3):437-43.

PMID:
3760271

Supplemental Content

Support Center